Immunome (IMNM) Cash from Operations (2019 - 2026)
Immunome's (IMNM) quarterly Cash from Operations came in at 58638000.0 in Q1 2026, down 10.52% YoY from 65534190.47 in Q1 2025, and down 22.28% on a QoQ basis from 47953000.0 in Q4 2025.
Powered by 
Analysis
Immunome (IMNM) Cash from Operations (2019 - 2026) Analysis & Trends
Immunome (IMNM) has 8 years of Cash from Operations data on file, last reported at 58638000.0 in Q1 2026.
- Quarterly Cash from Operations fell 10.52% year-over-year to 58638000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 196502000.0 (down 28.7% YoY) and the FY2025 annual result came in at 190919000.0, down 72.32% from the prior year.
- Cash from Operations retreated to 58638000.0 in Q1 2026, from 47953000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 24173000.0 in Q1 2023 to a low of 58638000.0 in Q1 2026.
- A 5-year average of 23329941.18 and a median of 17459000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 479.12% — and 2025, when it sank 374.98%.
- Tracing IMNM's Cash from Operations over 5 years: stood at 6683000.0 in 2022, then plunged by 161.24% to 17459000.0 in 2023, then plunged by 140.91% to 42060000.0 in 2024, then dropped by 14.01% to 47953000.0 in 2025, then decreased by 22.28% to 58638000.0 in 2026.
- The last three Cash from Operations figures came in at 58638000.0 (Q1 2026), 47953000.0 (Q4 2025), and 40510000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Immunome | 3.03 Bn | 2.51 Bn | - | -61.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -61.69 Mn |
| Mar 31, 2026 | -58.64 Mn |
| Dec 31, 2025 | -47.95 Mn |
| Sep 30, 2025 | -40.51 Mn |
| Jun 30, 2025 | -49.40 Mn |
| Mar 31, 2025 | -53.06 Mn |
| Dec 31, 2024 | -42.06 Mn |
| Sep 30, 2024 | -34.17 Mn |
| Jun 30, 2024 | -23.40 Mn |
| Mar 31, 2024 | -11.17 Mn |
| Dec 31, 2023 | -17.46 Mn |
| Sep 30, 2023 | -8.61 Mn |
| Jun 30, 2023 | -5.67 Mn |
| Mar 31, 2023 | 24.17 Mn |
| Dec 31, 2022 | -6.68 Mn |
| Sep 30, 2022 | -7.57 Mn |
| Jun 30, 2022 | -8.06 Mn |
| Mar 31, 2022 | -6.38 Mn |
| Dec 31, 2021 | -6.81 Mn |
| Sep 30, 2021 | -4.15 Mn |